CATHETERISATION CARDIAC

This adverse event was reported 4438 times

These drugs are most commonly taken by patients reporting CATHETERISATION CARDIAC:

# Drug Count
0 AMBRISENTAN 807
1 SILDENAFIL CITRATE 461
2 ASPIRIN 412
3 MACITENTAN 411
4 TADALAFIL 395
5 TREPROSTINIL 391
6 ASPIRIN 325 MG 381
7 ASPIRIN 81 MG 381
8 FUROSEMIDE 317
9 SILDENAFIL 290
See all common drugs associated with CATHETERISATION CARDIAC

CATHETERISATION CARDIAC is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 BACITRACIN AND POLYMYXIN B SULFATE 1 0.0667
1 APROCITENTAN 1 0.0455
2 EMPAGLIFLOZIN, LINAGLIPTIN, METFORMIN HYDROCHLORIDE 3 0.0242
3 NEFAZODONE HYDROCHLORIDE 2 0.0165
4 RANOLAZINE 101 0.0096
5 HYDROCORTISONE ACETATE AND PRAMOXINE HYDROCHLORIDE 2 0.0094
6 SELEXIPAG 233 0.0089
7 EPOPROSTENOL 107 0.0082
8 CHLOROTHIAZIDE 10 0.0079
9 ILOPROST 7 0.0075
See all drugs enriched for association with CATHETERISATION CARDIAC

CATHETERISATION CARDIAC is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Interleukin-5 Antagonist [EPC] 13 0.0189
1 Lead Chelator [EPC] 1 0.0119
2 Anti-anginal [EPC] 101 0.0096
3 Prostacyclin Receptor Agonist [EPC] 233 0.0089
4 Prostacycline [EPC] 7 0.0075
5 Soluble Guanylate Cyclase Stimulator [EPC] 218 0.0064
6 Endothelin Receptor Antagonist [EPC] 1205 0.0060
7 PCSK9 Inhibitor [EPC] 153 0.0059
8 Provitamin D2 Compound [EPC] 163 0.0055
9 Guanylate Cyclase-C Agonist [EPC] 10 0.0048
See all drug classes enriched for association with CATHETERISATION CARDIAC